|
Tahir, Salahaldin A; Kurosaka, Shinji; Tanimoto, Ryuta et al. (2013) Serum caveolin-1, a biomarker of drug response and therapeutic target in prostate cancer models. Cancer Biol Ther 14:117-26
|
|
Tahir, Salahaldin A; Yang, Guang; Goltsov, Alexei et al. (2013) Caveolin-1-LRP6 signaling module stimulates aerobic glycolysis in prostate cancer. Cancer Res 73:1900-11
|
|
Kuo, Shu-Ru; Tahir, Salahaldin A; Park, Sanghee et al. (2012) Anti-caveolin-1 antibodies as anti-prostate cancer therapeutics. Hybridoma (Larchmt) 31:77-86
|
|
Yang, Guang; Goltsov, Alexei A; Ren, Chengzhen et al. (2012) Caveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancer. Mol Cancer Res 10:218-29
|
|
Yang, Guang; Park, Sanghee; Cao, Guangwen et al. (2010) MMTV promoter-regulated caveolin-1 overexpression yields defective parenchymal epithelia in multiple exocrine organs of transgenic mice. Exp Mol Pathol 89:9-19
|
|
Thompson, T C; Tahir, S A; Li, L et al. (2010) The role of caveolin-1 in prostate cancer: clinical implications. Prostate Cancer Prostatic Dis 13:6-11
|
|
Tahir, Salahaldin A; Park, Sanghee; Thompson, Timothy C (2009) Caveolin-1 regulates VEGF-stimulated angiogenic activities in prostate cancer and endothelial cells. Cancer Biol Ther 8:2286-96
|
|
Watanabe, Masami; Yang, Guang; Cao, Guangwen et al. (2009) Functional analysis of secreted caveolin-1 in mouse models of prostate cancer progression. Mol Cancer Res 7:1446-55
|
|
Floryk, Daniel; Thompson, Timothy C (2008) Antiproliferative effects of AVN944, a novel inosine 5-monophosphate dehydrogenase inhibitor, in prostate cancer cells. Int J Cancer 123:2294-302
|
|
Floryk, Daniel; Thompson, Timothy C (2008) Perifosine induces differentiation and cell death in prostate cancer cells. Cancer Lett 266:216-26
|
Showing the most recent 10 out of 40 publications
